Page last updated: 2024-10-29

avapro and Angina, Unstable

avapro has been researched along with Angina, Unstable in 1 studies

Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.

Angina, Unstable: Precordial pain at rest, which may precede a MYOCARDIAL INFARCTION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biasucci, LM1
Lombardi, M1
Piro, M1
Di Giannuario, G1
Liuzzo, G1
Crea, F1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Telmisartan vs Ramipril for Reduction of Inflammation and Recruitment of Endothelial Progenitor Cells After Acute Coronary Syndrome[NCT00702936]Phase 450 participants (Anticipated)Interventional2007-11-30Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for avapro and Angina, Unstable

ArticleYear
Irbesartan significantly reduces C reactive protein concentrations after 1 month of treatment in unstable angina.
    Heart (British Cardiac Society), 2005, Volume: 91, Issue:5

    Topics: Adult; Aged; Angina, Unstable; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; C-Reacti

2005